Bassam Damaj
CIK 1478733 · CHIEF EXECUTIVE OFFICER · last filed 2016-11-21
Bassam Damaj is a CHIEF EXECUTIVE OFFICER who has filed 19 SEC Form 4 insider transactions across 2 companies since 2010. Across all open-market trades the lifetime net is +$6.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.22M
2
19
$6.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SEELOS THERAPEUTICS, INC. (APRI) Delisted | President and CEO | 64,603 | — | — | $6.1K | 5 | 2012-08-23 |
| NEXM | President and CEO | 515,820 | $2.36 | $1.22M | $0 | 3 | 2010-05-26 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-11-21 | — | Grant (A) | — | $0 | |
| 2016-02-02 | — | Grant (A) | — | $0 | |
| 2015-06-29 | — | Grant (A) | +50 | $6 | |
| 2015-04-01 | — | Grant (A) | — | $0 | |
| 2014-02-21 | — | Conv (C) | +1,190,411 | $0 | |
| 2014-02-10 | — | Mixed | −20,000 | $0 | |
| 2013-06-14 | — | Buy (P) | +416,841 | $134.6K | |
| 2013-02-19 | — | Grant (A) | — | $0 | |
| 2013-02-13 | — | Buy (P) | +250,406 | $119.0K | |
| 2013-02-05 | — | Buy (P) | +250,406 | $119.0K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.